Background/Aim: Sentinel lymph node biopsy (SLNB) has replaced axillary lymph node
dissection (ALND) for axillary staging in patients with early-stage breast cancer. The need …

BACKGROUND Reliable predictors of metastatic involvement would enable a better
selection of candidate patients for sentinel lymph node biopsy (SLNB) and possibly allow …

Axillary nodal status is an important prognostic factor in guiding locoregional and systemic
treatment for breast cancer. Sentinel lymph node biopsy (SNB) has revolutionized axillary …

The next step of sentinel lymph node biopsy (SLNB) in breast cancer is to determine which
patients need axillary lymph node dissection (ALND) following a positive SLNB. A …

Purpose Sentinel lymph node (SLN) biopsy (SLNB) is the standard tool to stage the axilla of
breast cancer patients. This study aimed to identify the predictors of positive SLNB in …

Background Sentinel lymph node biopsy (SLNB) allows for staging of the axillary node
status in early-stage breast cancer (BC) patients and avoiding complete axillary lymph node …

Sentinel lymph node biopsy (SLNB) is a standard in diagnostic and therapeutic
management of patients with nonadvanced invasive breast cancer. The aim of this paper …

Sentinel lymph node biopsy (SLNB) was introduced 2 decades ago and thereafter validated
for routine surgical management of breast cancer, including cases treated with neoadjuvant …

Pathologic examination of the sentinel lymph nodes (SLNs) in patients with breast cancer
has been impacted by the publication of practicing changing trials over the last decade. With …

Aims: To identify factors predicting metastatic involvement of non sentinel axillary lymph
nodes in breast cancer patients who underwent sentinel lymph node (SLN) biopsy followed …